Wonder if there is a link: From Watson: Jansse
Post# of 30028
From Watson:
Janssen Sets A Course To Intercept Type 1 Diabetes Together With JDRF. Joseph Hedrick is with Janssen and very close to Saarma and JDRF with work, actually he's close to all investigators on the MANF project. You can do the digging and see correlations. He is focused on proteins to stop cell death, they are into root causation, not necessarily reducing symptoms. This will be huge for Amarantus. I feel this is more epic than Lympro, you have millions of people in dire need, many in their youth losing limbs, vision, dying. I would suspect an agreement will arise in the next month with MANF. I'm not undermining ALZ, just the market for Diabetes is far more advantageous since it affects young and old
Urano:
CNS Regenerative Therapy. CNS?
CNS stands for “Central Nervous System.” CNS means brain, spinal cord, and neuronal cells in our body. I have been developing the regenerative therapy group for diseases in the central nervous system together with neurosurgeons, neurologists, and bioengineers in our hospitals. Wolfram syndrome is one of our target diseases. Although patients with Wolfram syndrome develop diabetes mellitus first, their major problems are optic nerve atrophy and neurodegeneration. We plan to announce our initiative soon.